[go: up one dir, main page]
Skip to main content

Purpose-Built for
Tech & Life Sciences

CaseStudy_Day1 home hero tile
Fenwick Client Insight

Fenwick Represents Day One Biopharmaceuticals in $2.5B Acquisition by Servier

Learn More

Fenwick Represents Figma in its $1.2B Initial Public Offering

CaseStudy_Figma2
Figma

Fenwick Represents Figma in its $1.2B Initial Public Offering

Fenwick Acts as Lead Transaction Counsel to Wiz in its $32 Billion Acquisition by Google

CaseStudy_Wiz
Wiz

Fenwick Acts as Lead Transaction Counsel to Wiz in its $32 Billion Acquisition by Google

Fenwick Represents Wealthfront in its $484M Initial Public Offering

CaseStudy_Wealthfront
 

Fenwick Represents Wealthfront in its $484M Initial Public Offering

Life Sciences & Tech

Practice Group of the Year

Law360, 2024

40%

Counsel on more than 40% of the highest value technology IPOs in 2025

Deal Point Data, 2025

$25B+

Business counsel to nearly 50% of US tech companies valued above $25B

Pitchbook, 2025

Fenwick Represents CoreWeave in its $1.5B Initial Public Offering, the Second Largest Tech IPO Since 2022

CaseStudy_Coreweave_2025
CoreWeave

Fenwick Represents CoreWeave in its $1.5B Initial Public Offering, the Second Largest Tech IPO Since 2022

Fenwick Secures $30.5 Million Jury Verdict for Lashify in Patent Infringement Case

Casestudy_Lashify
Lashify

Fenwick Secures $30.5 Million Jury Verdict for Lashify in Patent Infringement Case

Dedicated to helping technology
and life sciences companies
thrive at every stage of growth.

  • Logo archer black
  • Logo attovia black
  • Cisco BLACK logo
  • Coinbase BLACK logo
  • Logo coreweave black
  • Databricks BLACK logo
  • Logo devotedhealth black
  • Dexcom BLACK logo
  • Docusign BLACK logo
  • Logo figma black

Trusted by Top-Tier Technology and Life Sciences Companies

News, Trends, and Insights

Read insightful media interviews, in-depth surveys that guide boardroom discussions, flash reports that synthesize market indicators, and more.

Our Insights